Jonathan M. Weiss

11.0k citations

129 papers · 6.2k indexed · 2 hit papers · h-index 41

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Virology top 2%

Papers in

Immunology 58
- Immune Cell Function and Interaction 25
- Immunotherapy and Immune Responses 18
- Immune cells in cancer 16
- T-cell and B-cell Immunology 8
- Immunodeficiency and Autoimmune Disorders 8
Oncology 36
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 8

Co-authors: Wayne A. Smith Robert H. Wiltrout Joan W. Berman Jeffrey Subleski Daniel W. McVicar Eugene O. Major Luke C. Davies Avindra Nath
Journals: The Journal of Immunology (10 papers)Blood (7 papers)Cancer Research (6 papers)Scientific Reports (4 papers)PLoS ONE (4 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Jonathan M. Weiss

118 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 2012 · 424 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 American Journal of Obstetrics and Gynecology
1995 AIAA Journal

Peers

Countries citing papers authored by Jonathan M. Weiss

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Weiss more than expected).

Fields of papers citing papers by Jonathan M. Weiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Weiss. The network helps show where Jonathan M. Weiss may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan M. Weiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan M. Weiss Line = papers co-authored together Jonathan M. Weiss links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR European Journal Of Haematology ·Jan‐Michel Heger, Suk-Hee Yoon, 임창교, Bayer Mf, Jonathan M. Weiss, Lilis Setiyaningrum, Christian Becker, Kerstin Becker, Philipp Gödel, L Baccioni, Jörn Meinel, Washington Pico-Rodríguez, Florian Simon, Hans Christian Reinhardt, Peter Borchmann, Sven Borchmann, Hyatt Balke‐Want, Gero Knittel, Bastian von Tresckow	2024	5
2	The Personalized Acne Treatment Tool — Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of Experts JAAD International ·Alison Layton, Andrew Alexis, Hilary Baldwin, Vincenzo Bettoli, J.Q. Del Rosso, Thomas Dirschka, Brigitte Dréno, Linda Stein Gold, Julie Harper, Joo Yeon Ko, Zhenyu Luo, Hazel H. Oon, Murlidhar Rajagopalan, Marco Rocha, Jo‐Ann See, Jonathan M. Weiss, Jerry Tan	2023	11
3	Circulating Tumor DNA–Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax Clinical Cancer Research ·Moritz Fürstenau, Jonathan M. Weiss, 哲植丁, Lilis Setiyaningrum, Sandra Robrecht, Anna‐Maria Fink, Kirsten Fischer, Christof Schneider, Eugen Tausch, Stephan Stilgenbauer, Matthias Ritgen, Anke Schilhabel, Monika Brüggemann, Barbara Eichhorst, Michael Hallek, Paula Cramer	2022	17
4	Estimations of Competence in Neurodevelopmental Conditions: A Review SHILAP Revista de lepidopterología ·Michela Tollin, Nadin Madera Arias, Jonathan M. Weiss, Maggie E. Toplak	2019	0
5	Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer Journal of Thoracic Oncology ·Alexander Drilon, Jennifer Clark, Jonathan M. Weiss, Dariusz Chru 'sci 'nski, Omprakash R Pal, Benjamin Solomon, Remigiusz, Liza C. Villaruz, G. Riely, Robert B. Vandover, Gary R. Shapiro, Danielle Murphy, William F Daehler, Tiziana Usari, Christoph Oliver Mayer, K. Wilner, Paul K. Paik	2018	6
6	P3.03-29 The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer Journal of Thoracic Oncology ·Jessica S. Yang, Michael Cabanero, Mor Moskovitz, Jonathan M. Weiss, Melania Pintilie, Natasha B. Leighl, Penelope A. Bradbury, Enrique Ramírez Guerrero, 윤예준, Thomas J. Pugh, Dax Torti, Jonathon Torchia, Ming‐Sound Tsao, F. Shepherd	2018	1
7	NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay Cancer Research ·Lisa A. Ridnour, Robert Y.S. Cheng, Jonathan M. Weiss, Sukhbir Kaur, David R. Soto‐Pantoja, Debashree Basudhar, Julie L. Heinecke, Charles A. Stewart, William DeGraff, Anastasia L. Sowers, Angela Thetford, Aparna H. Kesarwala, David D. Roberts, Howard A. Young, James B. Mitchell, Giorgio Trinchieri, Robert H. Wiltrout, David A. Wink	2015	35
8	TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis Cancer Discovery ·Yanli Pang, Sudheer Kumar Gara, Bhagelu R. Achyut, Zhaoyang Li, Hannah H. Yan, Chi‐Ping Day, Jonathan M. Weiss, Giorgio Trinchieri, John C. Morris, Yang Li	2013	129
9	The Need for Federal Solutions to Interstate and International Ethics Conflicts: A Case Study in Confidentiality Jonathan M. Weiss	2012	2
10	ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors Clinical Cancer Research ·Johannes M. Heuckmann, Michael Hölzel, Martin L. Sos, Stefanie Heynck, Hyatt Balke‐Want, Mirjam Koker, Martin Peifer, Jonathan M. Weiss, Christine M. Lovly, Christian Grütter, Daniel Rauh, William Pao, Roman K. Thomas	2011	147
11	mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment Cancer Research ·Qun Jiang, Jonathan M. Weiss, Timothy Back, Tim Hon Man Chan, John R. Ortaldo, Sylvie M. Guichard, Robert H. Wiltrout	2011	71
12	Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors Cancer Research ·Jimmy K. Stauffer, Anthony J. Scarzello, Jesper B. Andersen, D Libei, Timothy Back, Jonathan M. Weiss, Snorri S. Thorgeirsson, Robert H. Wiltrout	2011	68
13	Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation Cancer Research ·Martin L. Sos, Haridas B. Rode, Stefanie Heynck, Martin Peifer, Florian Fischer, Sabine Klüter, Claudia P. Cartaya Marin, Katherine Nguyen, Johannes M. Heuckmann, Jonathan M. Weiss, Lars Ruddigkeit, Matthias Rabiller, Mirjam Koker, Jeffrey R. Simard, Matthäus Getlik, Yuki Yuza, Tzu-Hsiu Chen, Heidi Greulich, Roman K. Thomas, Daniel Rauh	2010	175
14	Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis Cancer Research ·S. Perwez Hussain, Peijun He, Jeffrey Subleski, Lorne J. Hofseth, Glenwood E. Trivers, Leah E. Mechanic, Anne B. Hofseth, Mark E. Bernard, Jonathan Schwank, Giang Huong Nguyen, Ewy A. Mathé, Draginja Djurickovic, Diana C. Haines, Jonathan M. Weiss, Timothy Back, Eilene Gruys, Victor E. Laubach, Robert H. Wiltrout, Curtis C. Harris	2008	85
15	Differential modulation of NK and NKT cells in the liver and spleen following IL-18 + IL-12 treatment of mice (98.9) The Journal of Immunology ·Jeff Subleski, Veronica L. Hall, Jonathan M. Weiss, John R. Ortaldo, Robert H. Wiltrout	2007	1
16	Immunotherapy of cancer by IL-12-based cytokine combinations Expert Opinion on Biological Therapy ·Jonathan M. Weiss, Jeffrey Subleski, Jon M. Wigginton, Robert H. Wiltrout	2007	166
17	Efficient Responses in a Murine Renal Tumor Model by Electroloading Dendritic Cells With Whole-Tumor Lysate Journal of Immunotherapy ·Jonathan M. Weiss, Cornell Allen, Rama Shivakumar, A. R. Egypt, Linhong Li, Linda N. Liu	2005	12
18	Solution of unsteady, low Mach number flow using a preconditioned multi-stage scheme on an unstructured mesh Jonathan M. Weiss, Wayne A. Smith	1993	2
19	Arthur Buies Et Les Etats-Unis Au XIXe Siecle Quebec Studies ·Jonathan M. Weiss	1987	0
20	The Contemporary Theater and Its Public in Québec Quebec Studies ·Jonathan M. Weiss	1983	0

About Jonathan M. Weiss

Jonathan M. Weiss is a scholar working on Immunology, Oncology, Cancer Research, Computational Mechanics and Pathology and Forensic Medicine, having authored 129 papers that have together received 6.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (25 papers), Immunotherapy and Immune Responses (18 papers), Immune cells in cancer (16 papers), Computational Fluid Dynamics and Aerodynamics (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), T-cell and B-cell Immunology (8 papers), CAR-T cell therapy research (8 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). The work is most often cited by research in Immunology (2.3k citations), Virology (299 citations), Oncology (1.5k citations), Computational Mechanics (1.0k citations) and Cancer Research (726 citations). Jonathan M. Weiss has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Wayne A. Smith, Robert H. Wiltrout, Joan W. Berman, Jeffrey Subleski, Daniel W. McVicar, Eugene O. Major, Luke C. Davies, Avindra Nath, Timothy Back and William J. Murphy. Their work appears in journals such as The Journal of Immunology, Blood, Cancer Research, Scientific Reports and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact